Oral Anticancer Drugs: Mechanisms of Low Bioavailability and Strategies for Improvement
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oral Anticancer Drugs: Mechanisms of Low Bioavailability and Strategies for Improvement
Authors
Keywords
Gefitinib, Solid Dispersion, Topotecan, Dasatinib, Axitinib
Journal
CLINICAL PHARMACOKINETICS
Volume 52, Issue 6, Pages 399-414
Publisher
Springer Nature
Online
2013-02-19
DOI
10.1007/s40262-013-0040-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Triazine dendrimers as drug delivery systems: From synthesis to therapy
- (2012) Jongdoo Lim et al. ADVANCED DRUG DELIVERY REVIEWS
- The Anthelmintic Triclabendazole and Its Metabolites Inhibit the Membrane Transporter ABCG2/BCRP
- (2012) Borja Barrera et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Phenylalanine 368 of multidrug resistance-associated protein 4 (MRP4/ABCC4) plays a crucial role in substrate-specific transport activity
- (2012) Hanneke G.M. Wittgen et al. BIOCHEMICAL PHARMACOLOGY
- Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance
- (2012) Karthika Natarajan et al. BIOCHEMICAL PHARMACOLOGY
- Synthesis and biological evaluation of bifendate–chalcone hybrids as a new class of potential P-glycoprotein inhibitors
- (2012) Xiaoke Gu et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Metastatic breast cancer: We do need primary cost data
- (2012) J. Bonastre et al. BREAST
- Localization of breast cancer resistance protein (Bcrp) in endocrine organs and inhibition of its transport activity by steroid hormones
- (2012) Anita C. A. Dankers et al. CELL AND TISSUE RESEARCH
- Pharmacokinetics and Safety of Bortezomib in Patients with Advanced Malignancies and Varying Degrees of Liver Dysfunction: Phase I NCI Organ Dysfunction Working Group Study NCI-6432
- (2012) P. M. LoRusso et al. CLINICAL CANCER RESEARCH
- Week 96 Efficacy, Virology and Safety of Darunavir/r Versus Lopinavir/r in Treatment-Experienced Patients in TITAN
- (2012) Denes Banhegyi et al. CURRENT HIV RESEARCH
- Enhanced oral bioavailability of paclitaxel in pluronic/LHR mixed polymeric micelles: Preparation, in vitro and in vivo evaluation
- (2012) Fatima Zohra Dahmani et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Microemulsions for oral administration and their therapeutic applications
- (2012) Stéphane Gibaud et al. Expert Opinion on Drug Delivery
- Long-term efficacy and safety of once-daily fosamprenavir 1400 mg boosted by ritonavir 100 mg: the BOLD100 study
- (2012) G Blick et al. INTERNATIONAL JOURNAL OF STD & AIDS
- A phase 1 study of gemcitabine combined with dasatinib in patients with advanced solid tumors
- (2012) David S. Hong et al. INVESTIGATIONAL NEW DRUGS
- Pharmacokinetics, tissue distribution and anti-tumour efficacy of paclitaxel delivered by polyvinylpyrrolidone solid dispersion
- (2012) Xiangrui Liu et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial
- (2012) Ralf-Dieter Hofheinz et al. LANCET ONCOLOGY
- Patients’ preferences for treatment outcomes for advanced non-small cell lung cancer: A conjoint analysis
- (2012) John F.P. Bridges et al. LUNG CANCER
- A Pharmacodynamic Study of the P-glycoprotein Antagonist CBT-1(R) in Combination With Paclitaxel in Solid Tumors
- (2012) R. J. Kelly et al. ONCOLOGIST
- Expression of ABC Efflux Transporters in Placenta from Women with Insulin-Managed Diabetes
- (2012) Gregory J. Anger et al. PLoS One
- Antiretroviral Simplification with Darunavir/Ritonavir Monotherapy in Routine Clinical Practice: Safety, Effectiveness, and Impact on Lipid Profile
- (2012) José R. Santos et al. PLoS One
- Soluplus-Solubilized Citrated Camptothecin—A Potential Drug Delivery Strategy in Colon Cancer
- (2011) Naveen K. Thakral et al. AAPS PHARMSCITECH
- Intestinal lymphatic transport for drug delivery
- (2011) Jaime A. Yáñez et al. ADVANCED DRUG DELIVERY REVIEWS
- Phase I Study of Oral Gemcitabine Prodrug (LY2334737) Alone and in Combination with Erlotinib in Patients with Advanced Solid Tumors
- (2011) Stijn L.W. Koolen et al. CLINICAL CANCER RESEARCH
- Pharmacokinetics of Vandetanib: Three Phase I Studies in Healthy Subjects
- (2011) Paul Martin et al. CLINICAL THERAPEUTICS
- Impact of Abcc2 [Multidrug Resistance-Associated Protein (Mrp) 2], Abcc3 (Mrp3), and Abcg2 (Breast Cancer Resistance Protein) on the Oral Pharmacokinetics of Methotrexate and Its Main Metabolite 7-Hydroxymethotrexate
- (2011) M. L. H. Vlaming et al. DRUG METABOLISM AND DISPOSITION
- Physicians’ preferences for prescribing oral and intravenous anticancer drugs: A Discrete Choice Experiment
- (2011) Laure Benjamin et al. EUROPEAN JOURNAL OF CANCER
- Drug delivery strategies for poorly water-soluble drugs: the industrial perspective
- (2011) Peter van Hoogevest et al. Expert Opinion on Drug Delivery
- Bioavailability and pharmacokinetics of sorafenib suspension, nanoparticles and nanomatrix for oral administration to rat
- (2011) Xue-qing Wang et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Pharmaceutical development and preliminary clinical testing of an oral solid dispersion formulation of docetaxel (ModraDoc001)
- (2011) J.J. Moes et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Health Literacy and Outcomes Among Patients With Heart Failure
- (2011) Pamela N. Peterson JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Probiotics in the gastrointestinal diseases of the elderly
- (2011) G. Malaguarnera et al. Journal of Nutrition Health & Aging
- Randomly methylated β‐cyclodextrin derivatives enhance taxol permeability through human intestinal epithelial Caco‐2 cell monolayer
- (2011) Ferenc Fenyvesi et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Part 4: Pharmacogenetic Variability in Anticancer Pharmacodynamic Drug Effects
- (2011) M. J. Deenen et al. ONCOLOGIST
- Part 3: Pharmacogenetic Variability in Phase II Anticancer Drug Metabolism
- (2011) M. J. Deenen et al. ONCOLOGIST
- Part 1: Background, Methodology, and Clinical Adoption of Pharmacogenetics
- (2011) M. J. Deenen et al. ONCOLOGIST
- Part 2: Pharmacogenetic Variability in Drug Transport and Phase I Anticancer Drug Metabolism
- (2011) M. J. Deenen et al. ONCOLOGIST
- A Critical Analysis of the Interplay between Cytochrome P450 3A and P-Glycoprotein: Recent Insights from Knockout and Transgenic Mice
- (2011) R. A. B. van Waterschoot et al. PHARMACOLOGICAL REVIEWS
- Elevated BCRP/ABCG2 Expression Confers Acquired Resistance to Gefitinib in Wild-Type EGFR-Expressing Cells
- (2011) Yun-Ju Chen et al. PLoS One
- Abcg2 Overexpression Represents a Novel Mechanism for Acquired Resistance to the Multi-Kinase Inhibitor Danusertib in BCR-ABL-Positive Cells In Vitro
- (2011) Stefan Balabanov et al. PLoS One
- Tegafur/gimeracil/oteracil (S-1) approved for the treatment of advanced gastric cancer in adults when given in combination with cisplatin: a review comparing it with other fluoropyrimidine-based therapies
- (2011) Masao Kobayakawa et al. OncoTargets and Therapy
- Development and Pharmacological Evaluation of a PEG Based Nanoparticulate Camptothecin Analog for Oral Administration
- (2011) Vijaykumar Nekkanti et al. Current Drug Delivery
- Structure–activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP)
- (2010) Anne Pick et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Population pharmacokinetics of intravenously and orally administered docetaxel with or without co-administration of ritonavir in patients with advanced cancer
- (2010) Stijn L. W. Koolen et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- A phase 2 pilot trial of low-dose, continuous infusion, or “metronomic” paclitaxel and oral celecoxib in patients with metastatic melanoma
- (2010) Rupal S. Bhatt et al. CANCER
- Anticancer oral therapy: Emerging related issues
- (2010) Giuseppe Luigi Banna et al. CANCER TREATMENT REVIEWS
- Moving towards dose individualization of tyrosine kinase inhibitors
- (2010) Heinz-Josef Klümpen et al. CANCER TREATMENT REVIEWS
- A Pharmacodynamic Study of Docetaxel in Combination with the P-glycoprotein Antagonist Tariquidar (XR9576) in Patients with Lung, Ovarian, and Cervical Cancer
- (2010) R. J. Kelly et al. CLINICAL CANCER RESEARCH
- A Possible Cause and Remedy for the Clinical Failure of 5-Fluorouracil Plus Eniluracil
- (2010) Thomas Spector et al. Clinical Colorectal Cancer
- Variation of MDR proteins expression and activity levels according to clinical status and evolution of CML patients
- (2010) Flavia C. Vasconcelos et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Development of microemulsion of mitotane for improvement of oral bioavailability
- (2010) David Attivi et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- 426 Phase I study of oral CP-4126, a gemcitabine analog, in patients with advanced solid tumours
- (2010) F.E. Stuurman et al. EJC SUPPLEMENTS
- Differential inhibition of murine Bcrp1/Abcg2 and human BCRP/ABCG2 by the mycotoxin fumitremorgin C
- (2010) Lucía González-Lobato et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Paclitaxel in self-micro emulsifying formulations: oral bioavailability study in mice
- (2010) Roos L. Oostendorp et al. INVESTIGATIONAL NEW DRUGS
- Antiproliferative activity, mechanism of action and oral antitumor activity of CP-4126, a fatty acid derivative of gemcitabine, in in vitro and in vivo tumor models
- (2010) Andries M. Bergman et al. INVESTIGATIONAL NEW DRUGS
- Increased oral bioavailability of paclitaxel by its encapsulation through complex formation with cyclodextrins in poly(anhydride) nanoparticles
- (2010) M. Agüeros et al. JOURNAL OF CONTROLLED RELEASE
- The Effect of Novel Surfactants and Solutol® HS 15 on Paclitaxel Aqueous Solubility and Permeability Across a Caco-2 Monolayer
- (2010) Adam W.G. Alani et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- The Developability Classification System: Application of Biopharmaceutics Concepts to Formulation Development
- (2010) James M. Butler et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Review: physical chemistry of solid dispersions
- (2010) Sandrien Janssens et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Multidrug resistance gene (MDR1) polymorphisms correlate with imatinib response in chronic myeloid leukemia
- (2010) Ling-Na Ni et al. MEDICAL ONCOLOGY
- Capecitabine for locally advanced and metastatic colorectal cancer: A review
- (2010) Georgios V Koukourakis World Journal of Gastrointestinal Oncology
- Oral bioavailability of a novel paclitaxel formulation (Genetaxyl) administered with cyclosporin A in cancer patients
- (2009) Zyting Chu et al. ANTI-CANCER DRUGS
- Effect of food on the pharmacokinetics of erlotinib, an orally active epidermal growth factor receptor tyrosine-kinase inhibitor, in healthy individuals
- (2009) Jie Ling et al. ANTI-CANCER DRUGS
- Patient adherence and persistence with oral anticancer treatment
- (2009) K. Ruddy et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Evaluation of the exposure equivalence of oral versus intravenous temozolomide
- (2009) Blanca D. Diez et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- P-glycoprotein (P-gp/Abcb1), Abcc2, and Abcc3 Determine the Pharmacokinetics of Etoposide
- (2009) J. S. Lagas et al. CLINICAL CANCER RESEARCH
- Coadministration of Ritonavir Strongly Enhances the Apparent Oral Bioavailability of Docetaxel in Patients with Solid Tumors
- (2009) R. L. Oostendorp et al. CLINICAL CANCER RESEARCH
- Tyrosine Kinase Inhibitor Enhances the Bioavailability of Oral Irinotecan in Pediatric Patients With Refractory Solid Tumors
- (2009) Wayne L. Furman et al. JOURNAL OF CLINICAL ONCOLOGY
- Effects of Food on the Relative Bioavailability of Lapatinib in Cancer Patients
- (2009) Kevin M. Koch et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Study of the Effect of Gastric Acid pH Modulators on the Bioavailability of Oral Dasatinib in Healthy Subjects
- (2009) Timothy Eley et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Synthesis, Crystallization, and Biological Evaluation of an Orally Active Prodrug of Gemcitabine
- (2009) David M. Bender et al. JOURNAL OF MEDICINAL CHEMISTRY
- How important is intestinal cytochrome P450 3A metabolism?
- (2009) Antonius E. van Herwaarden et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- developmental therapeutics
- (2008) ANNALS OF ONCOLOGY
- Oral Administration of Gemcitabine in Patients with Refractory Tumors: A Clinical and Pharmacologic Study
- (2008) S. A. Veltkamp et al. CLINICAL CANCER RESEARCH
- Pharmacogenetic Pathway Analysis of Docetaxel Elimination
- (2008) SD Baker et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- P-glycoprotein inhibition by membrane cholesterol modulation
- (2008) Ferenc Fenyvesi et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Effect of P-glycoprotein inhibitor, verapamil, on oral bioavailability and pharmacokinetics of irinotecan in rats
- (2008) Tripta Bansal et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Self-microemulsifying drug delivery system (SMEDDS) improves anticancer effect of oral 9-nitrocamptothecin on human cancer xenografts in nude mice
- (2008) J LU et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Better understanding of dissolution behaviour of amorphous drugs by in situ solid-state analysis using Raman spectroscopy
- (2008) M SAVOLAINEN et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Pre-clinical evidence for altered absorption and biliary excretion of irinotecan (CPT-11) in combination with quercetin: Possible contribution of P-glycoprotein
- (2008) Tripta Bansal et al. LIFE SCIENCES
- Effect of the ATP-binding cassette drug transporters ABCB1, ABCG2, and ABCC2 on erlotinib hydrochloride (Tarceva) disposition in in vitro and in vivo pharmacokinetic studies employing Bcrp1-/-/Mdr1a/1b-/- (triple-knockout) and wild-type mice
- (2008) S. Marchetti et al. MOLECULAR CANCER THERAPEUTICS
- Potential Oral Delivery of 7-Ethyl-10-Hydroxy-Camptothecin (SN-38) using Poly(amidoamine) Dendrimers
- (2008) Rohit B. Kolhatkar et al. PHARMACEUTICAL RESEARCH
- Drug Insight: gastrointestinal and hepatic adverse effects of molecular-targeted agents in cancer therapy
- (2008) Yohann Loriot et al. Nature clinical practice. Oncology
- Effective oral chemotherapy for breast cancer: pillars of strength
- (2007) M. Findlay et al. ANNALS OF ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now